American Portfolios Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.56K | Sell |
60
-3
| -5% | -$228 | ﹤0.01% | 2851 |
|
|
2022
Q2 | $4.38K | Sell |
63
-21
| -25% | -$1.46K | ﹤0.01% | 2879 |
|
|
2022
Q1 | $6.96K | Buy |
84
+4
| +5% | +$331 | ﹤0.01% | 2833 |
|
|
2021
Q4 | $6.01K | Sell |
80
-110
| -58% | -$8.26K | ﹤0.01% | 2828 |
|
|
2021
Q3 | $22.1K | Buy |
190
+7
| +4% | +$813 | ﹤0.01% | 2240 |
|
|
2021
Q2 | $40.6K | Buy |
183
+83
| +83% | +$18.4K | ﹤0.01% | 1837 |
|
|
2021
Q1 | $13.2K | Hold |
100
| – | – | ﹤0.01% | 2260 |
|
|
2020
Q4 | $17.3K | Buy |
100
+50
| +100% | +$8.65K | ﹤0.01% | 1878 |
|
|
2020
Q3 | $5.57K | Sell |
50
-1,158
| -96% | -$129K | ﹤0.01% | 2230 |
|
|
2020
Q2 | $71.6K | Buy |
1,208
+1,008
| +504% | +$59.8K | ﹤0.01% | 1155 |
|
|
2020
Q1 | $13.5K | Buy |
200
+100
| +100% | +$6.73K | ﹤0.01% | 1687 |
|
|
2019
Q4 | $8.43K | Sell |
100
-530
| -84% | -$44.7K | ﹤0.01% | 2068 |
|
|
2019
Q3 | $47.1K | Buy |
+630
| New | +$47.1K | ﹤0.01% | 1303 |
|